Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia: Correlation between VEGF expression and the FAB category

American Journal of Clinical Pathology

Volumn 119, Issue 5, 2003, Pages 663-671

  Ghannadan, Minoo ^a   Wimazal, Friedrich ^a   Simonitsch, Ingrid ^a   Sperr, Wolfgang R ^a   Mayerhofer, Matthias ^a   Sillaber, Christian ^a   Hauswirth, Alexander W ^a   Gadner, Helmut ^b   Chott, Andreas ^a   Horny, Hans Peter ^c   Lechner, Klaus ^a   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

AML; Angiogenesis; Leukemia; VEGF

Indexed keywords

RNA; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; MESSENGER RNA; SIGNAL PEPTIDE; VASCULOTROPIN A;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL MATURATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROID CELL; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEGAKARYOCYTE; MYELOBLAST; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; ACUTE MONOCYTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; BONE MARROW CELL; CHEMISTRY; CLASSIFICATION; COHORT ANALYSIS; ERYTHROLEUKEMIA; GENETICS; METABOLISM; MIDDLE AGED; MYELOID LEUKEMIA; MYELOMONOCYTIC LEUKEMIA; PATHOLOGY; PRESCHOOL CHILD; PROMYELOCYTIC LEUKEMIA;

ADOLESCENT; ADULT; AGED; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; LYMPHOKINES; MALE; MIDDLE AGED; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 85047688441     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/331QX7AXKWFJFKXM     Document Type: Article

References (30)

1. Vellenga E, Griffin JD. The biology of acute myeloid leukemia. Semin Oncol. 1987;14:365-371.
2. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341:1051-1062.
3. Bitter MA, Le Beau MM, Rowley JD, et al. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol. 1987;18:211-225.
4. Grimwade D, Walker H, Oliver F, et al, for the Medical Research Council Adult and Children's Leukaemia Working Parties. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood. 1998;92:2322-2333.
5. Strout MP, Marcucci G, Caligiuri MA, et al. Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: biology and clinical implications. Ann Hematol. 1999;78:251-264.
6. Baer MR, Bloomfield CD. Multidrug resistance in acute myeloid leukemia. J Natl Cancer Inst. 1991;83:663-665.
7. Appelbaum FR. Molecular diagnosis and clinical decisions in adult acute leukemia. Semin Hematol. 1999;36:401-410.
8. Bennett JM, Catovsky D, Daniel MT, et al, for the French-American-British (FAB) Co-operative Group. Proposals for the classification of the acute leukaemias. Br J Hematol. 1976;33:451-458.
9. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-625.
10. Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:460-462.
11. Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol. 1991;78:325-329.
12. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
13. Brunning RD, Matures E, Flandrin G, et al. Acute myeloid leukemia with recurrent genetic abnormalities. In: Jaffe NL, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:81-87. World Health Organization Classification of Tumours.
14. Fiedler W, Graeven U, Ergün S, et al. Vascular endothelial cell growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood. 1997;89:1870-1875.
15. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood. 2000;96:2240-2245.
16. Aguayo A, Estey E, Kantarjian H, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood. 1999;94:3717-3721.
17. Fiedler W, Graeven U, Ergün S, et al. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia. 1997;11:1234-1237.
18. De Bont ES, Rosati S, Jacobs S, et al. Increased bone marrow vascularization in patients with acute myeloid leukemia: a possible role for vascular endothelial growth factor. Br J Haematol. 2001;113:296-304.
19. Padro T, Bieker R, Ruiz S, et al. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGVR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia. 2002;16:1302-1310.
20. Bellamy WT, Richter L, Sirjani D, et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood. 2001;97:1427-1434.
21. Wimazal F, Jordan J-H, Sperr WR, et al. Increased angiogenesis in the bone marrow of patients with systemic mastocytosis. Am J Pathol. 2002;160:1639-1645.
22. Mayerhofer M, Valent P, Sperr WR, et al. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, HIF-1α, through a pathway involving PI3-kinase and the mammalian target of rapamycin (mTOR). Blood. 2002;100:3767-3775.
23. Chomczynski P. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal Biochem. 1992;201:134-139.
24. Gerber HP, Malik AK, Solar GP, et al. VEGF regulates hematopoietic stem cell survival by an internal autocrine loop mechanism. Nature. 2002;417:954-958.
25. Mohle R, Green D, Moore MA, et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A. 1997;94:663-668.
26. Banks RE, Forbes MA, Kinsy SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer. 1989;77:956-964.
27. Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood. 2000;95:2637-2644.
28. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood. 2000;95:309-313.
29. Albitar M. Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome. Acta Hematol. 2001;106:170-176.
30. Watari M, Miwa H, Shikami M, et al. Expression of endothelial cell-associated molecules in AML cells. Leukemia. 2002;16:112-119.